150
Participants
Start Date
September 18, 2024
Primary Completion Date
September 3, 2025
Study Completion Date
September 9, 2025
TJ0113
200 mg or 400 mg Capsule, Once Daily
Placebo
Capsule, Once Daily
Second Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou
Taizhou Hospital
OTHER
Wenzhou Central Hospital
OTHER
Sir Run Run Shaw Hospital
OTHER
The Second Affiliated Hospital of Jiaxing University
OTHER
Hangzhou PhecdaMed Co., Ltd.
INDUSTRY
Huzhou Central Hospital
OTHER
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER